India Initiates anti dumping probe against import of ATS-8 from China
Arch Pharma Labs has filed the application
Arch Pharma Labs has filed the application
The govt has rolled out three schemes for promoting the manufacture of API
The scheme incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The highest reduction in prices for Pulse Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by importers
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
The group now has 320 approvals and has so far filed over 400 ANDAs
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.
Subscribe To Our Newsletter & Stay Updated